美股異動|禾賽盤前漲近7% 獲得零跑汽車20萬個激光雷達訂單
全球領先的激光雷達企業禾賽科技(HSAI.US)盤前大漲6.89%,報14.12美元。消息上,日前,零跑汽車與禾賽科技在零跑科技總部正式達成深化戰略合作,後續零跑預計將採購約20萬臺的禾賽ATX激光雷達,覆蓋零跑2025年起多款量產車型。公司稱,ATX激光雷達已獲得11家國內外主機廠的幾十款量產車型定點,2025年第一季度已開始向主機廠量產交付。此次戰略合作的深化,推動零跑高階智駕技術以及激光雷達從“高端選配”到“安全標配”的升級。(格隆匯)

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.